What is the recommended dosage, safety profile, and contraindications for pine bark extract tablets (Pycnogenol)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pine Bark Extract (Pycnogenol) Tablets

Pine bark extract should be held 2 weeks before surgery due to antiplatelet effects and bleeding risk, but can be used for various chronic conditions at 50-200 mg daily with good safety profile in non-surgical contexts. 1

Perioperative Management (Priority Guideline)

The Society for Perioperative Assessment and Quality Improvement (SPAQI) 2021 consensus statement provides clear guidance 1:

  • Hold 2 weeks before surgery due to:
    • Anti-inflammatory effects
    • Antiplatelet activity
    • Concern for increased perioperative bleeding
    • Potential hepatotoxicity in large doses

This is the most critical safety consideration and takes precedence over other uses.

Dosing Recommendations

Based on FDA-labeled products and clinical research:

  • Standard dosing: 50-200 mg daily 2, 3, 4
  • Typical regimen: 100 mg daily (50 mg twice daily at 9 AM and 9 PM) 5
  • Low-dose option: 50 mg daily has shown efficacy for oxidative stress reduction 6
  • Higher dose: 150-200 mg daily for metabolic syndrome and back pain 3, 4
  • Duration: Most clinical benefits observed within 2-8 weeks, with studies ranging 4 weeks to 6 months 5, 7, 4

Pediatric Considerations

Consult healthcare professional for children under 12 years 2. One study in children with ADHD used age-appropriate dosing, but evidence remains very limited 8.

Safety Profile

Overall tolerability is excellent across multiple studies:

  • No serious adverse events reported in most clinical trials 3, 5, 7, 4
  • Compliance rates >98% in studies 7
  • Well-tolerated at doses up to 200 mg daily for 6 months 3, 4

Specific Warnings from FDA Labeling 2:

  • Pregnancy/breastfeeding: Consult healthcare professional before use
  • Children under 3: Do not use unless directed by physician
  • Overdose: Contact Poison Control immediately
  • Storage: Keep in cool, dry place

Drug Interactions

The SPAQI guideline notes potential interactions through hepatic metabolism, though specific pathways are not detailed for pine bark extract 1. The antiplatelet effects suggest caution with:

  • Warfarin
  • Antiplatelet agents
  • NSAIDs
  • Other anticoagulants

Contraindications

Absolute contraindications:

  • Scheduled surgery within 2 weeks 1
  • Known hypersensitivity to pine bark extract

Relative contraindications/cautions:

  • Active bleeding disorders
  • Concurrent anticoagulant therapy (requires monitoring)
  • Severe hepatic impairment (due to potential hepatotoxicity in large doses) 1
  • Pregnancy and breastfeeding (insufficient safety data)

Clinical Applications with Evidence

While the Cochrane review found very low-certainty evidence across conditions 8, individual studies suggest potential benefits in:

  • Metabolic syndrome: 150 mg daily for 6 months improved waist circumference, triglycerides, blood pressure, HDL cholesterol, and fasting glucose 4
  • Back pain: 200 mg daily improved pain scores and mobility faster than standard management alone 3
  • Oxidative stress: 50 mg daily significantly reduced reactive oxygen species in smokers 6
  • Menopausal symptoms: 100 mg daily for 8 weeks reduced hot flushes, night sweats, and mood swings 7

Critical Caveats

  1. Evidence quality: Despite multiple studies, the 2020 Cochrane review concluded that small sample sizes and methodological limitations prevent definitive conclusions about efficacy 8

  2. Bleeding risk: The antiplatelet effects are the primary safety concern requiring the 2-week preoperative discontinuation 1

  3. Hepatotoxicity: Large doses may cause liver toxicity, though this is poorly defined in the literature 1

  4. Not FDA-approved: Products are marketed as dietary supplements, not FDA-evaluated medications 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.